Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus R Herrlinger

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Expert Opinion on Biological Therapy|January 24, 2014
Therapeutic peptides in inflammatory bowel diseaseKlaus R Herrlinger, Eduard F Stange, Klaus Fellermann
World Journal of Gastroenterology|August 29, 2006
Extraintestinal manifestations and complications in inflammatory bowel diseasesKatja S Rothfuss, Eduard F Stange, Klaus R Herrlinger
Inflammatory Bowel Diseases|March 15, 2008
Azathioprine-induced suicidal erythrocyte deathCorinna Geiger, Michael Föller, Klaus R Herrlinger, et al.
European Journal of Gastroenterology & Hepatology|July 4, 2003
Crohn's disease: a defensin deficiency syndrome?Klaus Fellermann, Jan Wehkamp, Klaus R Herrlinger, et al.
Gastroenterology|February 28, 2004
6-thioguanine-buried alive?Klaus R Herrlinger, Matthias Schwab, Klaus Fellermann, et al.
Clinical Pharmacokinetics|March 3, 2007
Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosingAlexander Teml, Elke Schaeffeler, Klaus R Herrlinger, et al.
Inflammatory Bowel Diseases|October 9, 2004
Fatal staphylococcal sepsis in Crohn's disease after infliximabKlaus R Herrlinger, Annette Borutta, Gabriel Meinhardt, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Mechanisms of disease: defensins in gastrointestinal diseasesJan Wehkamp, Klaus Fellermann, Klaus R Herrlinger, et al.
Visceral Medicine|June 1, 2017
Arguments for and against Centralization in Oncologic Visceral MedicineTobias Keck Chair, Klaus R Herrlinger Chair, Siegbert Faiss, et al.
Inflammatory Bowel Diseases|December 14, 2002
Response of refractory colitis to intravenous or oral tacrolimus (FK506)Klaus Fellermann, Zita Tanko, Klaus R Herrlinger, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Expert Opinion on Biological Therapy|January 24, 2014
Therapeutic peptides in inflammatory bowel diseaseKlaus R Herrlinger, Eduard F Stange, Klaus Fellermann
World Journal of Gastroenterology|August 29, 2006
Extraintestinal manifestations and complications in inflammatory bowel diseasesKatja S Rothfuss, Eduard F Stange, Klaus R Herrlinger
Inflammatory Bowel Diseases|March 15, 2008
Azathioprine-induced suicidal erythrocyte deathCorinna Geiger, Michael Föller, Klaus R Herrlinger, et al.
European Journal of Gastroenterology & Hepatology|July 4, 2003
Crohn's disease: a defensin deficiency syndrome?Klaus Fellermann, Jan Wehkamp, Klaus R Herrlinger, et al.
Gastroenterology|February 28, 2004
6-thioguanine-buried alive?Klaus R Herrlinger, Matthias Schwab, Klaus Fellermann, et al.
Clinical Pharmacokinetics|March 3, 2007
Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosingAlexander Teml, Elke Schaeffeler, Klaus R Herrlinger, et al.
Inflammatory Bowel Diseases|October 9, 2004
Fatal staphylococcal sepsis in Crohn's disease after infliximabKlaus R Herrlinger, Annette Borutta, Gabriel Meinhardt, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Mechanisms of disease: defensins in gastrointestinal diseasesJan Wehkamp, Klaus Fellermann, Klaus R Herrlinger, et al.
Visceral Medicine|June 1, 2017
Arguments for and against Centralization in Oncologic Visceral MedicineTobias Keck Chair, Klaus R Herrlinger Chair, Siegbert Faiss, et al.
Inflammatory Bowel Diseases|December 14, 2002
Response of refractory colitis to intravenous or oral tacrolimus (FK506)Klaus Fellermann, Zita Tanko, Klaus R Herrlinger, et al.
Pageof 4